Primary Job Title Chief Executive Officer Primary Organization Nine Square Therapeutics
Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Robert joined Nine Square Therapeutics as CEO in January 2022. Before coming to Nine Square, he served as chief medical officer of Alector, a biotechnology company pioneering novel therapeutic approaches for the treatment of neurodegenerative diseases by targeting immune dysfunction as a root cause of multiple pathologies that drive degenerative
brain disorders. Robert joined Alector from Genentech, where between 2009 and 2016 he held various leadership roles in the company’s Medical and Neuroscience Clinical Development organizations. Prior to joining Genentech, he spent several years as a neurologist at the University of Munich and also was a consultant at Boston Consulting Group.
